The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

Description

Currently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term opioid use. Given the increasing opioid abuse and over-prescription post-operatively, an effort should be made to determine whether one time dosing of Methadone, a longer opioid analgesics, intra-operatively is an adequate potential in treating postoperative pain after hysterectomy surgeries. The investigators hypothesize that this could minimize the need for additional post-operative and outpatient opioid prescriptions and decrease the adverse effects that are associated with the consumption, including new opioid abuse. Intervention group will receive methadone intraoperatively while the other group would receive short-acting opioids (standard).

Conditions

Fibroid Uterus

Study Overview

Study Details

Study overview

Currently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term opioid use. Given the increasing opioid abuse and over-prescription post-operatively, an effort should be made to determine whether one time dosing of Methadone, a longer opioid analgesics, intra-operatively is an adequate potential in treating postoperative pain after hysterectomy surgeries. The investigators hypothesize that this could minimize the need for additional post-operative and outpatient opioid prescriptions and decrease the adverse effects that are associated with the consumption, including new opioid abuse. Intervention group will receive methadone intraoperatively while the other group would receive short-acting opioids (standard).

A Randomized Controlled Trial to Study the Effects of One-time Intra-operative Dosing of Methadone During Laparoscopic or Robotic Hysterectomy in Reducing Opioid Prescription.

The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

Condition
Fibroid Uterus
Intervention / Treatment

-

Contacts and Locations

Baltimore

The Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States, 21224

Baltimore

The Johns Hopkins Hospital, Baltimore, Maryland, United States, 21287

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals with a uterus
  • * Age 18 years old and above
  • * Undergoing minimally invasive (laparoscopic or robotic) hysterectomy with ovarian preservation
  • * Benign indications for hysterectomy
  • * Agreeing to participate
  • * Chronic pain syndromes patients including fibromyalgia
  • * Patients currently on long-term (i.e. for more than three months) opioid use
  • * Patients currently on agonist-antagonist medications (e.g. buprenorphine)
  • * Patients taking a selective serotonin reuptake inhibitor or monoamine oxidase inhibitor
  • * Conversion to laparotomy
  • * Allergy or other contraindication to the prescribed medications such as methadone, fentanyl, acetaminophen or oxycodone
  • * Severe Obstructive Sleep Apnea (OSA)
  • * Pregnant/breastfeeding patients

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Johns Hopkins University,

Mostafa Borahay, MD, MBA, PhD, PRINCIPAL_INVESTIGATOR, Study Principal Investigator

Study Record Dates

2026-12